<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Adrenal masses can be detected in up to 4% of the population, and are mostly of adrenocortical origin </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="C0001618" disease_type="Neoplastic Process" abbrv="">Adrenocortical tumours</z:e> (ACTs) may be responsible for excess steroid production and, in the case of <z:e sem="disease" ids="C0346402" disease_type="Neoplastic Process" abbrv="">adrenocortical cancers</z:e>, for morbidity or mortality due to <z:e sem="disease" ids="C0598934" disease_type="Neoplastic Process" abbrv="">tumour growth</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Our understanding of the pathogenesis of ACTs is more limited than that for other <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>However, studies of the genetics of ACTs have led to major advances in this field in the last decade </plain></SENT>
<SENT sid="4" pm="."><plain>The identification of germline molecular defects in the hereditary syndrome responsible for ACTs has facilitated progress </plain></SENT>
<SENT sid="5" pm="."><plain>Indeed, similar molecular defects have since been identified as somatic alterations in <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>The <z:e sem="disease" ids="C0277558" disease_type="Disease or Syndrome" abbrv="">familial diseases</z:e> concerned are <z:e sem="disease" ids="C0085390" disease_type="Neoplastic Process" abbrv="LFS">Li-Fraumeni syndrome</z:e>, which may be due to germline mutation of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e>-suppressor gene TP53 and <z:e sem="disease" ids="C0004903" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Beckwith-Wiedemann syndrome</z:e>, which is caused by dys-regulation of the imprinted IGF-II locus at 11p15 </plain></SENT>
<SENT sid="7" pm="."><plain>ACTs also occur in type 1 multiple <z:hpo ids='HP_0100568'>endocrine neoplasia</z:hpo> (MEN 1), which is characterized by a germline mutation of the menin gene </plain></SENT>
<SENT sid="8" pm="."><plain><z:e sem="disease" ids="C0010481" disease_type="Disease or Syndrome" abbrv="">Cushing's syndrome</z:e> due to primary pigmented nodular adrenocortical disease (PPNAD) has been observed in <z:e sem="disease" ids="C0406810" disease_type="Disease or Syndrome" abbrv="NAME">Carney complex</z:e> patients presenting inactivating germline PRKAR1A mutations </plain></SENT>
<SENT sid="9" pm="."><plain>Interestingly, allelic losses at 17p13 and 11p15 have been demonstrated in <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:e sem="disease" ids="C0346402" disease_type="Neoplastic Process" abbrv="">adrenocortical cancer</z:e> and somatic PRKAR1A mutations have been found in secreting <z:hpo ids='HP_0008256'>adrenocortical adenomas</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain>More rarely, mutations in Gs protein (gsp) and the gene for ACTH receptor have been observed in ACTs </plain></SENT>
<SENT sid="11" pm="."><plain>The genetics of another group of <z:e sem="disease" ids="C0001621" disease_type="Disease or Syndrome" abbrv="">adrenal diseases</z:e> that can lead to adrenal nodular <z:mpath ids='MPATH_134'>hyperplasia</z:mpath> -- <z:hpo ids='HP_0008258'>congenital adrenal hyperplasia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CAH</z:e>) and <z:chebi fb="1" ids="24261">glucocorticoid</z:chebi>-remediable <z:e sem="disease" ids="C0020428" disease_type="Disease or Syndrome" abbrv="">aldosteronism</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GRA</z:e>) -- have also been studied extensively </plain></SENT>
<SENT sid="12" pm="."><plain>This review summarizes recent advances in the genetics of ACTs, highlighting both improvements in our understanding of the pathophysiology and the diagnosis of these <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> </plain></SENT>
</text></document>